FDA Investigator: Clark Stuart, Michelle Y

- Clark Stuart, Michelle Y first started conducting FDA inspections in 2004, with the last inspection in 2012. Over that time, Clark Stuart, Michelle Y has conducted 17 inspections at 14 companies across 15 sites.

Get Clark Stuart, Michelle Y's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 DSM Pharmaceuticals Inc, Greenville | 2012

Out-of-stock
Clark Stuart, Michelle Y
Human Drug Form 483

FDA 483 Genzyme A Sanofi Company, Lynnwood | 2011

Out-of-stock
Clark Stuart, Michelle Y
Human Drug Form 483

FDA 483 Lonza Biologics, Inc., Portsmouth | 2010

Out-of-stock
Clark Stuart, Michelle Y
Human Drug Form 483

FDA 483 Bristol-Myers Squibb Co., Pharmaceutical Research Institute, East Syracuse | 2009

Out-of-stock
Clark Stuart, Michelle Y
Human Drug Form 483

FDA 483 Boehringer Ingelheim Pharma Gmbh & Co Kg, Biberach An Der Riss | 2008

Out-of-stock
Clark Stuart, Michelle Y
Human Drug Form 483

FDA 483 Regeneron Pharmaceuticals Inc, Rensselaer | 2007

Out-of-stock
Clark Stuart, Michelle Y
Human Drug Form 483

FDA 483 Boehringer Ingelheim Fremont, Inc., Fremont | 2006

Out-of-stock
Clark Stuart, Michelle Y
Human Drug Form 483

FDA 483 Amgen Manufacturing Limited, Inc., Juncos | 2005

Out-of-stock
Clark Stuart, Michelle Y
Human Drug Form 483